Company page

Adc Therapeutics Sa

Adc Therapeutics SA is a public company traded under the ticker ADCT in the American market, with a market capitalization of approximately $138.6 million. The company focuses on developing targeted therapies for patients with hematologic malignancies. Adc Therapeutics is committed to advancing its innovative treatment options to improve patient outcomes.